301 related articles for article (PubMed ID: 21803119)
1. Structural and functional analysis of domains of the progesterone receptor.
Hill KK; Roemer SC; Churchill ME; Edwards DP
Mol Cell Endocrinol; 2012 Jan; 348(2):418-29. PubMed ID: 21803119
[TBL] [Abstract][Full Text] [Related]
2. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.
Roemer SC; Donham DC; Sherman L; Pon VH; Edwards DP; Churchill ME
Mol Endocrinol; 2006 Dec; 20(12):3042-52. PubMed ID: 16931575
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.
Roemer SC; Adelman J; Churchill ME; Edwards DP
Nucleic Acids Res; 2008 Jun; 36(11):3655-66. PubMed ID: 18474528
[TBL] [Abstract][Full Text] [Related]
4. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor.
Tetel MJ; Jung S; Carbajo P; Ladtkow T; Skafar DF; Edwards DP
Mol Endocrinol; 1997 Jul; 11(8):1114-28. PubMed ID: 9212059
[TBL] [Abstract][Full Text] [Related]
5. The nonconserved hinge region and distinct amino-terminal domains of the ROR alpha orphan nuclear receptor isoforms are required for proper DNA bending and ROR alpha-DNA interactions.
McBroom LD; Flock G; Giguère V
Mol Cell Biol; 1995 Feb; 15(2):796-808. PubMed ID: 7823947
[TBL] [Abstract][Full Text] [Related]
6. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.
Hill KK; Roemer SC; Jones DN; Churchill ME; Edwards DP
J Biol Chem; 2009 Sep; 284(36):24415-24. PubMed ID: 19553667
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure.
Takimoto GS; Tung L; Abdel-Hafiz H; Abel MG; Sartorius CA; Richer JK; Jacobsen BM; Bain DL; Horwitz KB
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):209-19. PubMed ID: 12943706
[TBL] [Abstract][Full Text] [Related]
9. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.
Kumar R; Moure CM; Khan SH; Callaway C; Grimm SL; Goswami D; Griffin PR; Edwards DP
J Biol Chem; 2013 Oct; 288(42):30285-30299. PubMed ID: 23995840
[TBL] [Abstract][Full Text] [Related]
11. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways.
Edwards DP; Wardell SE; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):173-86. PubMed ID: 12650714
[TBL] [Abstract][Full Text] [Related]
13. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding.
Hsu MH; Palmer CN; Song W; Griffin KJ; Johnson EF
J Biol Chem; 1998 Oct; 273(43):27988-97. PubMed ID: 9774413
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.
Lavery DN; McEwan IJ
Biochem J; 2005 Nov; 391(Pt 3):449-64. PubMed ID: 16238547
[TBL] [Abstract][Full Text] [Related]
15. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
[TBL] [Abstract][Full Text] [Related]
16. Association of the Ku autoantigen/DNA-dependent protein kinase holoenzyme and poly(ADP-ribose) polymerase with the DNA binding domain of progesterone receptors.
Sartorius CA; Takimoto GS; Richer JK; Tung L; Horwitz KB
J Mol Endocrinol; 2000 Apr; 24(2):165-82. PubMed ID: 10750018
[TBL] [Abstract][Full Text] [Related]
17. The conserved residues of the ligand-binding domains of steroid receptors are located in the core of the molecules.
Maeda M
J Mol Graph Model; 2001; 19(6):543-51, 601-6. PubMed ID: 11552682
[TBL] [Abstract][Full Text] [Related]
18. Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics.
Zheng L; Lin VC; Mu Y
PLoS One; 2016; 11(11):e0165824. PubMed ID: 27824891
[TBL] [Abstract][Full Text] [Related]
19. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
Baulieu EE
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins.
Melvin VS; Roemer SC; Churchill ME; Edwards DP
J Biol Chem; 2002 Jul; 277(28):25115-24. PubMed ID: 12006575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
